A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-12

AUTHORS

Nadja M. Meindl-Beinker, Johannes Betge, Tobias Gutting, Elke Burgermeister, Sebastian Belle, Tianzuo Zhan, Nadine Schulte, Martin Maenz, Matthias P. Ebert, Nicolai Haertel

ABSTRACT

BACKGROUND: Advanced esophageal squamous cell cancer (ESCC) is frequently diagnosed in elderly patients. The impact of 2nd line chemotherapy is poorly defined. Recent data demonstrated effectiveness of checkpoint inhibitors in different squamous cell carcinomas. Therefore, we assess combined nivolumab/ipilimumab as 2nd line therapy in elderly ESCC patients. METHODS: RAMONA is a multicenter open-label phase II trial. The primary objective is to demonstrate a significant survival benefit of nivolumab/ipilimumab in advanced ESCC compared to historical data of standard chemotherapy. Primary endpoint is therefore overall survival (OS). Major secondary objective is the evaluation of tolerability. Time to QoL deterioration will thus be determined as key secondary endpoint. Further secondary endpoints are tumor response, PFS and safety. We aim to recruit a total of n = 75 subjects that have to be > 65 years old. Eligibility is determined by the geriatric status (G8 screening and Deficit Accumulation Frailty Index (DAFI)). A safety assessment will be performed after a 3 cycle run-in phase of nivolumab (240 mg Q2W) to justify escalation for eligible patients to combined nivolumab (240 mg Q2W) and ipilimumab (1 mg/kg Q6W), while the other patients will remain on nivolumab only. RAMONA also includes translational research sub-studies to identify predictive biomarkers, including PD-1 and PD-L1 evaluation at different time points, establishment of organoid cultures and microbiome analyses for response prediction. DISCUSSION: The RAMONA trial aims to implement checkpoint inhibitors for elderly patients with advanced ESCC as second line therapy. Novel biomarkers for checkpoint-inhibitor response are analyzed in extensive translational sub-studies. TRIAL REGISTRATION: EudraCT Number: 2017-002056-86 ; NCT03416244 , registered: 31.1.2018. More... »

PAGES

231

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12885-019-5446-2

DOI

http://dx.doi.org/10.1186/s12885-019-5446-2

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1112769049

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30871493


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University Medical Centre Mannheim", 
          "id": "https://www.grid.ac/institutes/grid.411778.c", 
          "name": [
            "Department of Medicine II, University Hospital Mannheim, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Meindl-Beinker", 
        "givenName": "Nadja M.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Medical Centre Mannheim", 
          "id": "https://www.grid.ac/institutes/grid.411778.c", 
          "name": [
            "Department of Medicine II, University Hospital Mannheim, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Betge", 
        "givenName": "Johannes", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Medical Centre Mannheim", 
          "id": "https://www.grid.ac/institutes/grid.411778.c", 
          "name": [
            "Department of Medicine II, University Hospital Mannheim, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gutting", 
        "givenName": "Tobias", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Medical Centre Mannheim", 
          "id": "https://www.grid.ac/institutes/grid.411778.c", 
          "name": [
            "Department of Medicine II, University Hospital Mannheim, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Burgermeister", 
        "givenName": "Elke", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Medical Centre Mannheim", 
          "id": "https://www.grid.ac/institutes/grid.411778.c", 
          "name": [
            "Department of Medicine II, University Hospital Mannheim, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Belle", 
        "givenName": "Sebastian", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Medical Centre Mannheim", 
          "id": "https://www.grid.ac/institutes/grid.411778.c", 
          "name": [
            "Department of Medicine II, University Hospital Mannheim, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhan", 
        "givenName": "Tianzuo", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Medical Centre Mannheim", 
          "id": "https://www.grid.ac/institutes/grid.411778.c", 
          "name": [
            "Department of Medicine II, University Hospital Mannheim, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schulte", 
        "givenName": "Nadine", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "AIO Studien gGmbH", 
          "id": "https://www.grid.ac/institutes/grid.476005.0", 
          "name": [
            "AIO-Studien gGmbH, Berlin, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Maenz", 
        "givenName": "Martin", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Medical Centre Mannheim", 
          "id": "https://www.grid.ac/institutes/grid.411778.c", 
          "name": [
            "Department of Medicine II, University Hospital Mannheim, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ebert", 
        "givenName": "Matthias P.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Medical Centre Mannheim", 
          "id": "https://www.grid.ac/institutes/grid.411778.c", 
          "name": [
            "Department of Medicine II, University Hospital Mannheim, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Haertel", 
        "givenName": "Nicolai", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1634/theoncologist.5-3-224", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005103018"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(15)00007-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008095212"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2188/jea.15.s212", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008873713"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2188/jea.15.s212", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008873713"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.canlet.2008.10.020", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011468018"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1610-0387.2010.07568.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014438058"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3727/096504016x14537290676865", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016232794"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/gut.2009.191080", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016645783"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(16)30098-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019058481"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(09)70326-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021910096"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2016.68.1478", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024418876"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2016.68.1478", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024418876"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1112088", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024545289"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.18632/oncotarget.6861", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027022021"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.30269", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031111613"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(16)30066-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031533236"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(16)30624-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034482273"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1602252", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036710957"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2011.36.7599", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039094870"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/0284186x.2016.1244356", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041236564"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/ddg.13047", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042403648"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrclinonc.2013.208", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043102499", 
          "https://doi.org/10.1038/nrclinonc.2013.208"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.18632/oncotarget.7582", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046841012"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1504627", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052572745"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/2162402x.2015.1046028", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1058420519"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.je.2016.12.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083759554"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.je.2016.12.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083759554"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(17)30104-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083854270"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(17)30181-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084052519"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(17)30380-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1085587597"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/j.gastro.2017.08.023", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091231881"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/j.gastro.2017.08.023", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091231881"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1709937", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091511599"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(17)31827-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092128619"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2017.74.3062", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092190944"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2017.74.9846", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092595046"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1712126", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1101673751"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2019.37.4_suppl.2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1111800212"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-12", 
    "datePublishedReg": "2019-12-01", 
    "description": "BACKGROUND: Advanced esophageal squamous cell cancer (ESCC) is frequently diagnosed in elderly patients. The impact of 2nd line chemotherapy is poorly defined. Recent data demonstrated effectiveness of checkpoint inhibitors in different squamous cell carcinomas. Therefore, we assess combined nivolumab/ipilimumab as 2nd line therapy in elderly ESCC patients.\nMETHODS: RAMONA is a multicenter open-label phase II trial. The primary objective is to demonstrate a significant survival benefit of nivolumab/ipilimumab in advanced ESCC compared to historical data of standard chemotherapy. Primary endpoint is therefore overall survival (OS). Major secondary objective is the evaluation of tolerability. Time to QoL deterioration will thus be determined as key secondary endpoint. Further secondary endpoints are tumor response, PFS and safety. We aim to recruit a total of n\u2009=\u200975 subjects that have to be >\u200965\u2009years old. Eligibility is determined by the geriatric status (G8 screening and Deficit Accumulation Frailty Index (DAFI)). A safety assessment will be performed after a 3\u2009cycle run-in phase of nivolumab (240\u2009mg Q2W) to justify escalation for eligible patients to combined nivolumab (240\u2009mg Q2W) and ipilimumab (1\u2009mg/kg Q6W), while the other patients will remain on nivolumab only. RAMONA also includes translational research sub-studies to identify predictive biomarkers, including PD-1 and PD-L1 evaluation at different time points, establishment of organoid cultures and microbiome analyses for response prediction.\nDISCUSSION: The RAMONA trial aims to implement checkpoint inhibitors for elderly patients with advanced ESCC as second line therapy. Novel biomarkers for checkpoint-inhibitor response are analyzed in extensive translational sub-studies.\nTRIAL REGISTRATION: EudraCT Number: 2017-002056-86 ; NCT03416244 , registered: 31.1.2018.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s12885-019-5446-2", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1024632", 
        "issn": [
          "1471-2407"
        ], 
        "name": "BMC Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "19"
      }
    ], 
    "name": "A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA)", 
    "pagination": "231", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "fb7674e0c0ff4e5e4ba44366ea0e0213ddcc35d6ecb892536e652c58b2702938"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30871493"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "100967800"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12885-019-5446-2"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1112769049"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12885-019-5446-2", 
      "https://app.dimensions.ai/details/publication/pub.1112769049"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T13:18", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000368_0000000368/records_78938_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs12885-019-5446-2"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12885-019-5446-2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12885-019-5446-2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12885-019-5446-2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12885-019-5446-2'


 

This table displays all metadata directly associated to this object as RDF triples.

227 TRIPLES      21 PREDICATES      63 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12885-019-5446-2 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author N2495deeb90e143a18d8bb2b84a61c23b
4 schema:citation sg:pub.10.1038/nrclinonc.2013.208
5 https://doi.org/10.1002/cncr.30269
6 https://doi.org/10.1016/j.canlet.2008.10.020
7 https://doi.org/10.1016/j.je.2016.12.002
8 https://doi.org/10.1016/s0140-6736(17)31827-5
9 https://doi.org/10.1016/s1470-2045(09)70326-2
10 https://doi.org/10.1016/s1470-2045(15)00007-8
11 https://doi.org/10.1016/s1470-2045(16)30066-3
12 https://doi.org/10.1016/s1470-2045(16)30098-5
13 https://doi.org/10.1016/s1470-2045(16)30624-6
14 https://doi.org/10.1016/s1470-2045(17)30104-3
15 https://doi.org/10.1016/s1470-2045(17)30181-x
16 https://doi.org/10.1016/s1470-2045(17)30380-7
17 https://doi.org/10.1053/j.gastro.2017.08.023
18 https://doi.org/10.1056/nejmoa1112088
19 https://doi.org/10.1056/nejmoa1504627
20 https://doi.org/10.1056/nejmoa1602252
21 https://doi.org/10.1056/nejmoa1709937
22 https://doi.org/10.1056/nejmoa1712126
23 https://doi.org/10.1080/0284186x.2016.1244356
24 https://doi.org/10.1080/2162402x.2015.1046028
25 https://doi.org/10.1111/ddg.13047
26 https://doi.org/10.1111/j.1610-0387.2010.07568.x
27 https://doi.org/10.1136/gut.2009.191080
28 https://doi.org/10.1200/jco.2011.36.7599
29 https://doi.org/10.1200/jco.2016.68.1478
30 https://doi.org/10.1200/jco.2017.74.3062
31 https://doi.org/10.1200/jco.2017.74.9846
32 https://doi.org/10.1200/jco.2019.37.4_suppl.2
33 https://doi.org/10.1634/theoncologist.5-3-224
34 https://doi.org/10.18632/oncotarget.6861
35 https://doi.org/10.18632/oncotarget.7582
36 https://doi.org/10.2188/jea.15.s212
37 https://doi.org/10.3727/096504016x14537290676865
38 schema:datePublished 2019-12
39 schema:datePublishedReg 2019-12-01
40 schema:description BACKGROUND: Advanced esophageal squamous cell cancer (ESCC) is frequently diagnosed in elderly patients. The impact of 2nd line chemotherapy is poorly defined. Recent data demonstrated effectiveness of checkpoint inhibitors in different squamous cell carcinomas. Therefore, we assess combined nivolumab/ipilimumab as 2nd line therapy in elderly ESCC patients. METHODS: RAMONA is a multicenter open-label phase II trial. The primary objective is to demonstrate a significant survival benefit of nivolumab/ipilimumab in advanced ESCC compared to historical data of standard chemotherapy. Primary endpoint is therefore overall survival (OS). Major secondary objective is the evaluation of tolerability. Time to QoL deterioration will thus be determined as key secondary endpoint. Further secondary endpoints are tumor response, PFS and safety. We aim to recruit a total of n = 75 subjects that have to be > 65 years old. Eligibility is determined by the geriatric status (G8 screening and Deficit Accumulation Frailty Index (DAFI)). A safety assessment will be performed after a 3 cycle run-in phase of nivolumab (240 mg Q2W) to justify escalation for eligible patients to combined nivolumab (240 mg Q2W) and ipilimumab (1 mg/kg Q6W), while the other patients will remain on nivolumab only. RAMONA also includes translational research sub-studies to identify predictive biomarkers, including PD-1 and PD-L1 evaluation at different time points, establishment of organoid cultures and microbiome analyses for response prediction. DISCUSSION: The RAMONA trial aims to implement checkpoint inhibitors for elderly patients with advanced ESCC as second line therapy. Novel biomarkers for checkpoint-inhibitor response are analyzed in extensive translational sub-studies. TRIAL REGISTRATION: EudraCT Number: 2017-002056-86 ; NCT03416244 , registered: 31.1.2018.
41 schema:genre research_article
42 schema:inLanguage en
43 schema:isAccessibleForFree true
44 schema:isPartOf N3fb95b7ef5204ff495187ac788becce3
45 Ncfd2d6d5f5e141d698c88a889e0891c9
46 sg:journal.1024632
47 schema:name A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA)
48 schema:pagination 231
49 schema:productId N00616b7544de4d52b8a00da5206a2c24
50 N0c84df5c2f074d3f86939516554212d7
51 N1f7869e94d054ffabb08d38605a23582
52 N1fcc556967064513b20b5051c0047879
53 N590d693d691a4afb8638029945a88519
54 schema:sameAs https://app.dimensions.ai/details/publication/pub.1112769049
55 https://doi.org/10.1186/s12885-019-5446-2
56 schema:sdDatePublished 2019-04-11T13:18
57 schema:sdLicense https://scigraph.springernature.com/explorer/license/
58 schema:sdPublisher Nd98f9cd989b847939053bdbaa5af5c68
59 schema:url https://link.springer.com/10.1186%2Fs12885-019-5446-2
60 sgo:license sg:explorer/license/
61 sgo:sdDataset articles
62 rdf:type schema:ScholarlyArticle
63 N00616b7544de4d52b8a00da5206a2c24 schema:name dimensions_id
64 schema:value pub.1112769049
65 rdf:type schema:PropertyValue
66 N0c84df5c2f074d3f86939516554212d7 schema:name pubmed_id
67 schema:value 30871493
68 rdf:type schema:PropertyValue
69 N1bcc07b6a4b041a9ad691972fbb666b9 rdf:first N9d62676620ac4904b131c4142ebe7066
70 rdf:rest Nd99586a34edd41198ec343511bc253d7
71 N1f7869e94d054ffabb08d38605a23582 schema:name readcube_id
72 schema:value fb7674e0c0ff4e5e4ba44366ea0e0213ddcc35d6ecb892536e652c58b2702938
73 rdf:type schema:PropertyValue
74 N1fcc556967064513b20b5051c0047879 schema:name doi
75 schema:value 10.1186/s12885-019-5446-2
76 rdf:type schema:PropertyValue
77 N2146f09826e742caa533f3ae150ac4bc schema:affiliation https://www.grid.ac/institutes/grid.411778.c
78 schema:familyName Belle
79 schema:givenName Sebastian
80 rdf:type schema:Person
81 N2495deeb90e143a18d8bb2b84a61c23b rdf:first N38f15923ee3b4b9bb01dce393f538009
82 rdf:rest Na0f8d0b03b01474e850ee14201bd846f
83 N2567fdacff194b91990d7504b8ed1ef5 schema:affiliation https://www.grid.ac/institutes/grid.411778.c
84 schema:familyName Ebert
85 schema:givenName Matthias P.
86 rdf:type schema:Person
87 N2a2353bcc1fb4e94ab5696c042c5c8e2 schema:affiliation https://www.grid.ac/institutes/grid.476005.0
88 schema:familyName Maenz
89 schema:givenName Martin
90 rdf:type schema:Person
91 N2adeb8128ec24a468432ecb4d64c2af4 rdf:first N2146f09826e742caa533f3ae150ac4bc
92 rdf:rest N861f78fa160a4e82b53ffb012538548a
93 N2d2956aaa125496287ee7c81883da51a rdf:first N2567fdacff194b91990d7504b8ed1ef5
94 rdf:rest N3f5f35c1c5994f1082c3cecb6d12ece8
95 N38f15923ee3b4b9bb01dce393f538009 schema:affiliation https://www.grid.ac/institutes/grid.411778.c
96 schema:familyName Meindl-Beinker
97 schema:givenName Nadja M.
98 rdf:type schema:Person
99 N3f5f35c1c5994f1082c3cecb6d12ece8 rdf:first N9ef091c205f147dd8836f8d6365c0202
100 rdf:rest rdf:nil
101 N3fb95b7ef5204ff495187ac788becce3 schema:volumeNumber 19
102 rdf:type schema:PublicationVolume
103 N590d693d691a4afb8638029945a88519 schema:name nlm_unique_id
104 schema:value 100967800
105 rdf:type schema:PropertyValue
106 N5b7a4a0b61f74b5f9469f4b15ef4bb85 rdf:first N84d846d6e27247308bd4ac7da95d1ea2
107 rdf:rest Ndb6ee19f2a004bc18e787a0762b1258c
108 N5f1081f2bd244815b7be43c296a90c4e schema:affiliation https://www.grid.ac/institutes/grid.411778.c
109 schema:familyName Burgermeister
110 schema:givenName Elke
111 rdf:type schema:Person
112 N84d846d6e27247308bd4ac7da95d1ea2 schema:affiliation https://www.grid.ac/institutes/grid.411778.c
113 schema:familyName Schulte
114 schema:givenName Nadine
115 rdf:type schema:Person
116 N861f78fa160a4e82b53ffb012538548a rdf:first Nff74d0988bbc4e5481d4da4ee025315c
117 rdf:rest N5b7a4a0b61f74b5f9469f4b15ef4bb85
118 N9d62676620ac4904b131c4142ebe7066 schema:affiliation https://www.grid.ac/institutes/grid.411778.c
119 schema:familyName Gutting
120 schema:givenName Tobias
121 rdf:type schema:Person
122 N9ef091c205f147dd8836f8d6365c0202 schema:affiliation https://www.grid.ac/institutes/grid.411778.c
123 schema:familyName Haertel
124 schema:givenName Nicolai
125 rdf:type schema:Person
126 Na0f8d0b03b01474e850ee14201bd846f rdf:first Nad32a35f023f415b8e62bfc960656548
127 rdf:rest N1bcc07b6a4b041a9ad691972fbb666b9
128 Nad32a35f023f415b8e62bfc960656548 schema:affiliation https://www.grid.ac/institutes/grid.411778.c
129 schema:familyName Betge
130 schema:givenName Johannes
131 rdf:type schema:Person
132 Ncfd2d6d5f5e141d698c88a889e0891c9 schema:issueNumber 1
133 rdf:type schema:PublicationIssue
134 Nd98f9cd989b847939053bdbaa5af5c68 schema:name Springer Nature - SN SciGraph project
135 rdf:type schema:Organization
136 Nd99586a34edd41198ec343511bc253d7 rdf:first N5f1081f2bd244815b7be43c296a90c4e
137 rdf:rest N2adeb8128ec24a468432ecb4d64c2af4
138 Ndb6ee19f2a004bc18e787a0762b1258c rdf:first N2a2353bcc1fb4e94ab5696c042c5c8e2
139 rdf:rest N2d2956aaa125496287ee7c81883da51a
140 Nff74d0988bbc4e5481d4da4ee025315c schema:affiliation https://www.grid.ac/institutes/grid.411778.c
141 schema:familyName Zhan
142 schema:givenName Tianzuo
143 rdf:type schema:Person
144 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
145 schema:name Medical and Health Sciences
146 rdf:type schema:DefinedTerm
147 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
148 schema:name Oncology and Carcinogenesis
149 rdf:type schema:DefinedTerm
150 sg:journal.1024632 schema:issn 1471-2407
151 schema:name BMC Cancer
152 rdf:type schema:Periodical
153 sg:pub.10.1038/nrclinonc.2013.208 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043102499
154 https://doi.org/10.1038/nrclinonc.2013.208
155 rdf:type schema:CreativeWork
156 https://doi.org/10.1002/cncr.30269 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031111613
157 rdf:type schema:CreativeWork
158 https://doi.org/10.1016/j.canlet.2008.10.020 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011468018
159 rdf:type schema:CreativeWork
160 https://doi.org/10.1016/j.je.2016.12.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083759554
161 rdf:type schema:CreativeWork
162 https://doi.org/10.1016/s0140-6736(17)31827-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092128619
163 rdf:type schema:CreativeWork
164 https://doi.org/10.1016/s1470-2045(09)70326-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021910096
165 rdf:type schema:CreativeWork
166 https://doi.org/10.1016/s1470-2045(15)00007-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008095212
167 rdf:type schema:CreativeWork
168 https://doi.org/10.1016/s1470-2045(16)30066-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031533236
169 rdf:type schema:CreativeWork
170 https://doi.org/10.1016/s1470-2045(16)30098-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019058481
171 rdf:type schema:CreativeWork
172 https://doi.org/10.1016/s1470-2045(16)30624-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034482273
173 rdf:type schema:CreativeWork
174 https://doi.org/10.1016/s1470-2045(17)30104-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083854270
175 rdf:type schema:CreativeWork
176 https://doi.org/10.1016/s1470-2045(17)30181-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1084052519
177 rdf:type schema:CreativeWork
178 https://doi.org/10.1016/s1470-2045(17)30380-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085587597
179 rdf:type schema:CreativeWork
180 https://doi.org/10.1053/j.gastro.2017.08.023 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091231881
181 rdf:type schema:CreativeWork
182 https://doi.org/10.1056/nejmoa1112088 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024545289
183 rdf:type schema:CreativeWork
184 https://doi.org/10.1056/nejmoa1504627 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052572745
185 rdf:type schema:CreativeWork
186 https://doi.org/10.1056/nejmoa1602252 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036710957
187 rdf:type schema:CreativeWork
188 https://doi.org/10.1056/nejmoa1709937 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091511599
189 rdf:type schema:CreativeWork
190 https://doi.org/10.1056/nejmoa1712126 schema:sameAs https://app.dimensions.ai/details/publication/pub.1101673751
191 rdf:type schema:CreativeWork
192 https://doi.org/10.1080/0284186x.2016.1244356 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041236564
193 rdf:type schema:CreativeWork
194 https://doi.org/10.1080/2162402x.2015.1046028 schema:sameAs https://app.dimensions.ai/details/publication/pub.1058420519
195 rdf:type schema:CreativeWork
196 https://doi.org/10.1111/ddg.13047 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042403648
197 rdf:type schema:CreativeWork
198 https://doi.org/10.1111/j.1610-0387.2010.07568.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1014438058
199 rdf:type schema:CreativeWork
200 https://doi.org/10.1136/gut.2009.191080 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016645783
201 rdf:type schema:CreativeWork
202 https://doi.org/10.1200/jco.2011.36.7599 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039094870
203 rdf:type schema:CreativeWork
204 https://doi.org/10.1200/jco.2016.68.1478 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024418876
205 rdf:type schema:CreativeWork
206 https://doi.org/10.1200/jco.2017.74.3062 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092190944
207 rdf:type schema:CreativeWork
208 https://doi.org/10.1200/jco.2017.74.9846 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092595046
209 rdf:type schema:CreativeWork
210 https://doi.org/10.1200/jco.2019.37.4_suppl.2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1111800212
211 rdf:type schema:CreativeWork
212 https://doi.org/10.1634/theoncologist.5-3-224 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005103018
213 rdf:type schema:CreativeWork
214 https://doi.org/10.18632/oncotarget.6861 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027022021
215 rdf:type schema:CreativeWork
216 https://doi.org/10.18632/oncotarget.7582 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046841012
217 rdf:type schema:CreativeWork
218 https://doi.org/10.2188/jea.15.s212 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008873713
219 rdf:type schema:CreativeWork
220 https://doi.org/10.3727/096504016x14537290676865 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016232794
221 rdf:type schema:CreativeWork
222 https://www.grid.ac/institutes/grid.411778.c schema:alternateName University Medical Centre Mannheim
223 schema:name Department of Medicine II, University Hospital Mannheim, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany
224 rdf:type schema:Organization
225 https://www.grid.ac/institutes/grid.476005.0 schema:alternateName AIO Studien gGmbH
226 schema:name AIO-Studien gGmbH, Berlin, Germany
227 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...